Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults
Clinical trial NCT06585891 · COMPLETED
Trial details
- NCT number
- NCT06585891
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-07
- Primary completion
- 2025-09-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.